ID   KP-4-1
AC   CVCL_8727
SY   KP 4-1; KP4-1
DR   CLO; CLO_0050110
DR   cancercelllines; CVCL_8727
DR   GEO; GSM1588609
DR   GEO; GSM1588621
DR   RCB; RCB1006
DR   Wikidata; Q54900372
RX   PubMed=21559554;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C3850; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1338 ! KP-4
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 20
//
RX   PubMed=21559554; DOI=10.3892/ijo.5.1.33;
RA   Nishi Y., Haji M., Takayanagi R., Iguchi H., Shimazoe T., Hirata J.,
RA   Nawata H.;
RT   "Establishment and characterization of PTHrP-producing human
RT   pancreatic-cancer cell-line.";
RL   Int. J. Oncol. 5:33-39(1994).
//